• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXHL1502244 依鲁替尼胶囊 ibrutinib Capsule Chemical Drugs(3.1) New Drug Application 2016-02-16 浙江海正药业股份有限公司 Zhejiang Hisun Pharmaceutical Co Ltd Certificate Issued 2017-03-01 view
CXHL1502219 依鲁替尼胶囊 ibrutinib Capsule Chemical Drugs(3.1) New Drug Application 2016-03-11 哈尔滨珍宝制药有限公司 Harbin Zhenbao Pharmaceutical Co Ltd Certificate Issued 2017-03-15 view
CXHL1502114 依鲁替尼胶囊 ibrutinib Capsule Chemical Drugs(3.1) New Drug Application 2016-02-25 上海汇伦江苏药业有限公司 Shanghai Huilun (Jiangsu) Pharmaceutical Co Ltd Certificate Issued 2017-03-07 view
CXHL1402176 依鲁替尼胶囊 ibrutinib Capsule Chemical Drugs(3.1) New Drug Application 2015-01-23 杭州中美华东制药有限公司 Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd Certificate Issued 2016-05-12 view
CXHL1501520 依鲁替尼胶囊 ibrutinib Capsule Chemical Drugs(3.1) New Drug Application 2015-08-05 江苏万邦生化医药股份有限公司 Wanbang Biopharmaceuticals Certificate Issued 2016-08-23 view
CXHL1502243 依鲁替尼 ibrutinib Active ingredient Chemical Drugs(3.1) New Drug Application 2016-02-16 浙江海正药业股份有限公司 Zhejiang Hisun Pharmaceutical Co Ltd Certificate Issued 2017-03-01 view
CXHL1502218 依鲁替尼 ibrutinib Active ingredient Chemical Drugs(3.1) New Drug Application 2016-03-11 黑龙江珍宝岛药业股份有限公司鸡西分公司 Jixi Branch of Heilongjiang Zhenbaodao Pharmaceutical Co Ltd Certificate Issued 2017-03-15 view
CXHL1501519 依鲁替尼 ibrutinib Active ingredient Chemical Drugs(3.1) New Drug Application 2015-08-05 徐州万邦金桥制药有限公司 Xuzhou Wanbang Jinqiao Pharmaceutical Co Ltd Certificate Issued 2016-08-12 view
CXHL1502113 依鲁替尼 ibrutinib Active ingredient Chemical Drugs(3.1) New Drug Application 2016-02-25 上海汇伦江苏药业有限公司 Shanghai Huilun (Jiangsu) Pharmaceutical Co Ltd Certificate Issued 2017-03-07 view
CXHL1402175 依鲁替尼 ibrutinib Active ingredient Chemical Drugs(3.1) New Drug Application 2015-01-23 杭州中美华东制药有限公司 Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd Certificate Issued 2016-05-19 view
CYHS2400274 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs(4) Generic Drug 2024-01-20 Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd view
JYHB1900203 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs Supplementary Application 2019-02-22 Pharmacyclics LLC Pharmacyclics Inc Certificate Issued 2019-04-04 view
CXHL1500546 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs(3.1) New Drug Application 2015-04-30 山东新鲁医药有限公司 Shandong Newroad MEDICINE Co Ltd Certificate Issued 2016-08-04 view
CYHS2402914 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs(4) Generic Drug 2024-09-04 view
JYHB2100105 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs Supplementary Application 2021-02-02 Janssen-Cilag International NV Janssen-Cilag International NV Certificate Issued 2021-03-09 view
CYHS2300103 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs(4) Generic Drug 2023-01-11 view
JYHB1701174 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs Supplementary Application 2017-09-18 Pharmacyclics LLC Pharmacyclics Inc Certificate Issued 2018-04-18 view
JXHL1300519 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs Import Drug Application 2014-01-13 Pharmacyclics, Inc. Pharmacyclics Inc Certificate Issued 2016-10-28 view
CYHS2402581 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs(4) Generic Drug 2024-08-09 Kinhoo Pharmaceutical Co Ltd view
JYHB2000345 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs Supplementary Application 2020-04-10 Pharmacyclics LLC Pharmacyclics Inc Certificate Issued 2020-06-12 view